Relationship between corticotherapy and increased cardiac risk in patients with rheumatoid arthritis
Braz. J. Pharm. Sci. (Online)
; 57: e19156, 2021. tab, graf
Article
em En
| LILACS
| ID: biblio-1350240
Biblioteca responsável:
BR40.1
Localização: BR40.1
ABSTRACT
Rheumatoid arthritis is an autoimmune inflammatory joint disease with global prevalence of 0.4% to 1.0%. Extra-articular manifestations increase its morbidity and severity, and cardiovascular diseases present the greatest risk. Therapeutic approaches have been used to treat rheumatoid arthritis, often involving the use of multiple classes of drugs with different mechanisms and forms of action. Corticosteroid therapy is widely used in this therapeutic combination; however, its use has been widely questioned because of its high toxicity and some negative effects, including the possibility of increased cardiovascular risk, depending on the dosage. Some studies have provided important insights into how glucocorticoids have an impact on cardiac complications in patients with rheumatoid arthritis. Most of these studies have concluded that exposure to these drugs at high or cumulative doses is associated with increased risk of death, as well as possibly being associated with the presence of a positive rheumatoid factor.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Acesso_medicamentos_insumos_estrategicos
Base de dados:
LILACS
Assunto principal:
Artrite Reumatoide
/
Doenças Cardiovasculares
/
Fatores de Risco de Doenças Cardíacas
/
Glucocorticoides
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Braz. J. Pharm. Sci. (Online)
Ano de publicação:
2021
Tipo de documento:
Article